LC-SRM combined with machine learning enables fast identification and quantification of bacterial pathogens in urinary tract infections.

Urinary tract infections (UTIs) are a worldwide health problem. Fast and accurate detection of bacterial infection is essential to provide appropriate antibiotherapy to patients and to avoid the emergence of drug-resistant pathogens. While the gold standard requires 24h to 48h of bacteria culture prior MALDI-TOF species identification, we propose a culture-free workflow, enabling a bacterial identification and quantification in less than 4 hours using 1mL of urine. After a rapid and automatable sample preparation, a signature of 82 bacterial peptides, defined by machine learning, was monitored in LC-MS, to distinguish the 15 species causing 84% of the UTIs. The combination of the sensitivity of the SRM mode on a triple quadrupole TSQ Altis instrument and the robustness of capillary flow enabled us to analyze up to 75 samples per day, with 99.2% accuracy on bacterial inoculations of healthy urines. We have also shown our method can be used to quantify the spread of the infection, from 8x104 to 3x107 CFU/mL. Finally, the workflow was validated on 45 inoculated urines and on 84 UTI-positive urine from patients, with respectively 93.3% and 87.1% of agreement with the culture-MALDI procedure at a level above 1x105 CFU/mL corresponding to an infection requiring antibiotherapy.

A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers.

The sensitivity of LC-MS in quantifying target proteins in plasma/tissues is significantly hindered by coeluted matrix interferences. While antibody-based immuno-enrichment effectively reduces interferences, developing and optimizing antibodies are often time-consuming and costly. Here, by leveraging the orthogonal separation capability of Field Asymmetric Ion Mobility Spectrometry (FAIMS), we developed a FAIMS/differential-compensation-voltage (FAIMS/dCV) method for antibody-free, robust, and ultrasensitive quantification of target proteins directly from plasma/tissue digests. By comparing the intensity-CV profiles of the target vs coeluted endogenous interferences, the FAIMS/dCV approach identifies the optimal CV for quantification of each target protein, thus maximizing the signal-to-noise ratio (S/N). Compared to quantification without FAIMS, this technique dramatically reduces endogenous interferences, showing a median improvement of the S/N by 14.8-fold for the quantification of 17 representative protein drugs and biomarkers in plasma or tissues and a 5.2-fold median increase in S/N over conventional FAIMS approach, which uses the peak CV of each target. We also discovered that the established CV parameters remain consistent over months and are matrix-independent, affirming the robustness of the developed FAIMS/dCV method and the transferability of the method across matrices. The developed method was successfully demonstrated in three applications: the quantification of monoclonal antibodies with subng/mL LOQ in plasma, an investigation of the time courses of evolocumab and its target PCSK9 in a preclinical setting, and a clinical investigation of low abundance obesity-related biomarkers. This innovative and easy-to-use method has extensive potential in clinical and pharmaceutical research, particularly where sensitive and high-throughput quantification of protein drugs and biomarkers is required.

Paper spray mass spectrometry - A potential complementary technique for the detection of polar compounds in sports drug testing.

In this proof-of-concept study, paper spray mass spectrometry was investigated as a high-throughput and fully automated technique for the initial testing of particularly polar compounds that are prohibited in sports. The technique allows the ionization of analytes from complex sample matrices such as blood and urine when spotted onto a paper strip. By minimizing sample preparation and omitting chromatographic separation, paper spray mass spectrometry benefits from considerable cost- and time-savings compared with conventional high performance liquid chromatography/tandem mass spectrometry, especially in cases where conventional reversed-phase liquid chromatography offers limited applicability. All but one of the investigated model compounds fulfilled the World Anti-Doping Agency's (WADA's) requirements regarding the applicable minimum required performance limits for initial testing procedures. In addition, the combination of paper spray mass spectrometry and ion mobility separation results in enhanced selectivity and sensitivity and is a particularly valuable analytical configuration.

Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice.

BACKGROUND: NEO212 is a novel small-molecule anticancer agent that was generated by covalent conjugation of the natural monoterpene perillyl alcohol (POH) to the alkylating agent temozolomide (TMZ). It is undergoing preclinical development as a therapeutic for brain-localized malignancies. The aim of this study was to characterize metabolism and pharmacokinetic (PK) properties of NEO212 in preclinical models. METHODS: We used mass spectrometry (MS) and modified high-performance liquid chromatography to identify and quantitate NEO212 and its metabolites in cultured glioblastoma cells, in mouse plasma, brain, and excreta after oral gavage. RESULTS: Our methods allowed identification and quantitation of NEO212, POH, TMZ, as well as primary metabolites 5-aminoimidazole-4-carboxamide (AIC) and perillic acid (PA). Intracellular concentrations of TMZ were greater after treatment of U251TR cells with NEO212 than after treatment with TMZ. The half-life of NEO212 in mouse plasma was 94 min. In mice harboring syngeneic GL261 brain tumors, the amount of NEO212 was greater in the tumor-bearing hemisphere than in the contralateral normal hemisphere. The brain:plasma ratio of NEO212 was greater than that of TMZ. Excretion of unaltered NEO212 was through feces, whereas its AIC metabolite was excreted via urine. CONCLUSIONS: NEO212 preferentially concentrates in brain tumor tissue over normal brain tissue, and compared to TMZ has a higher brain:plasma ratio, altogether revealing favorable features to encourage its further development as a brain-targeted therapeutic. Its breakdown into well-characterized, long-lived metabolites, in particular AIC and PA, will provide useful equivalents for PK studies during further drug development and clinical trials with NEO212.

Photoelectron spectroscopy of chloro-substituted phenylnitrene anions.

The 355 nm time-of-flight negative ion photoelectron spectra of (o-, m-, and p-chlorophenyl)nitrene radical anions are reported. Electron affinities are obtained from the photoelectron spectra, and are 1.79 +/- 0.05, 1.82 +/- 0.05, and 1.72 +/- 0.05 eV for the (o-, m-, and p-chlorophenyl)nitrenes, respectively. Singlet-triplet splittings are determined to be 14 +/- 2, 15 +/- 1, and 14 +/- 2 kcal/mol, respectively. The shapes of the photoelectron bands indicate resonance interactions in the singlet states for the ortho- and para-substituted isomers, which is attributed to quinoidal structures of the open-shell singlet states. Reanalysis of the photoelectron spectrum of phenylnitrene anion leads to a revised experimental singlet-triplet splitting of 14.8 kcal/mol in the unsubstituted phenylnitrene.

Structure and reactivity of benzoylnitrene radical anion in the gas phase.

The open-shell benzoylnitrene radical anion, readily generated by electron ionization of benzoylazide, undergoes unique chemical reactivity with radical reagents and Lewis acids in the gas phase. Reaction with nitric oxide, NO, proceeds by loss of N2 and formation of benzoate ion. This novel reaction is also observed to occur with phenylnitrene anion, forming phenoxide. Similar reactivity was observed in the reaction between benzoylnitrene radical anion and NO2, forming benzoate ion and nitrous oxide. Electronic structure calculations indicate that the reaction has a high-energy barrier that is overcome by the energy released by bond formation. Benzoylnitrene radical anion also transfers oxygen anion to NO and NO2 as well as to CS2 and SO2. In contrast, phenylnitrene anion reacts with carbon disulfide by C+ or CS+ abstraction, forming S- or S2-. Electronic structure calculations indicate that benzoylnitrene in the ground state resembles a slightly polarized benzoate anion, but with a free radical localized on the nitrogen.

Thermochemical studies of benzoylnitrene radical anion: the N-H bond dissociation energy in benzamide in the gas phase.

The thermochemical properties of benzoylnitrene radical anion, C6H5CON-, were determined by using a combination of energy-resolved collision-induced dissociation (CID) and proton affinity bracketing. Benzoylnitrene radical anion dissociates upon CID to give NCO- and phenyl radical with a dissociation enthalpy of 0.85 +/- 0.09 eV, which is used to derive an enthalpy of formation of 33 +/- 9 kJ/mol for the nitrene radical anion. Bracketing studies with the anion indicate a proton affinity of 1453 +/- 10 kJ/mol, indicating that the acidity of benzamidyl radical, C6H5CONH, is between those of benzamide and benzoic acid. Combining the measurements gives an enthalpy of formation for benzamidyl radical of 110 +/- 14 kJ/mol and a homolytic N-H bond dissociation energy in benzamide of 429 +/- 14 kJ/mol. Additional thermochemical properties obtained include the electron affinity of benzamidyl radical, the hydrogen atom affinity of benzoylnitrene radical anion, and the oxygen anion affinity of benzonitrile.

Benzoylnitrene radical anion: a new reagent for the generation of M-2H anions.

Benzoylnitrene radical anion, formed in high abundance by electron ionization of benzoylazide, is found to be a useful reagent for the formation of ionized reactive intermediates, such as diradicals and carbenes. The reactivity of the ion is similar to what is observed with atomic oxygen anion, occurring in many instances by H(2)(+) transfer. However, because benzoylnitrene radical anion is less basic than oxygen anion, it undergoes H(2)(+) transfer with substrates that react with oxygen anion by only proton transfer and therefore can be used to generate reactive ions not easily prepared by other methodologies.